Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Gastric Antisecretory Drug Market from 2024 to 2025?
The market size of gastric antisecretory drugs has been experiencing robust growth in recent times. The market is set to expand from $14.87 billion in 2024 to $15.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. This substantial growth during the historical period can be traced back to factors such as increased stress levels and sedentary living habits, a surge in helicobacter pylori infections, encouraging government health policies, an uptick in medical tourism, and the growth of e-commerce and online pharmacies.
What Is the Projected Market Size of the Gastric Antisecretory Drug Market?
The market for gastric antisecretory drugs is predicted to achieve considerable growth in the upcoming years. The market size is expected to reach $19.97 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth may include increased incidence of gastrointestinal issues, an aging population, greater awareness of digestive health, improvements in healthcare infrastructure, and a rise in the intake of processed and fast foods. Key trends projected to influence the market in the forecast period comprise a broad application of NSAIDs, over-the-counter (OTC) accessibility of antisecretory medications, advancements in drug delivery technology, the provisions of generic drugs, and progress in the field of combination therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24222&type=smp
Who are the Major Competitors in the Gastric Antisecretory Drug Market Outlook?
Major companies operating in the gastric antisecretory drug market are Pfizer Inc., Bayer AG, AstraZeneca plc, Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Chemo Biological, Spansules Pharmatech Pvt. Ltd., Phoenix Biologicals Pvt. Ltd., Centurion Remedies Private Limited, Solitaire Pharmacia Pvt. Ltd., Shreeji Pharma International, Estrellas Life Sciences Private Limited, 3s Corporation, Actiza Pharmaceutical Private Limited, Lark Laboratories, Cytonova Labs International Private Limited, Luckys Pharma Lab Pvt. Ltd., Lexicare Pharma Pvt. Ltd., Mustcure Healthcare LLP
What Is Fueling Growth in the Gastric Antisecretory Drug Market?
The upsurge of gastrointestinal ailments is expected to instigate the expansion of the gastric antisecretory drug market in the foreseeable future. Conditions affecting the digestive system, including the stomach, intestines, and related organs, result in symptoms such as discomfort, bloating, and irregular bowel activities. The surge in such disorders is predominantly motivated by improper eating habits, with the excess consumption of processed food and lack of sufficient fiber upsetting the balance of gut microbiota and hindering digestion. There is a need for gastric antisecretory medications since excess stomach acid can harm the protective lining of the digestive system, causing irritation or injury that these medications prevent by decreasing acid output. For example, a report released by the American bibliographic database ScienceDirect in May 2025 stated that approximately 23.5 million gastrointestinal endoscopies were undertaken in 2022. Thus, the rising frequency of gastrointestinal conditions augments the growth of the gastric antisecretory drug market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24222&type=smp
Which Gastric Antisecretory Drug Market Segments Are Growing the Fastest?
The gastric antisecretory drug market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors (PPIs), H2 Receptor Antagonists, Antacids, Prostaglandin Analogs
2) By Route Of Administration: Oral, Intravenous, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome, Other Applications
Subsegments:
1) By Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole
2)By H2 Receptor Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Magnesium Hydroxide, Calcium Carbonate, Aluminum Hydroxide, Sodium Bicarbonate, Combination Antacids
4) By Prostaglandin Analogs: Misoprostol, Enprostil
Which Industry Trends Are Shaping the Future of the Gastric Antisecretory Drug Market?
Prominent businesses in the gastric antisecretory drug market are prioritizing the creation of advanced products like antisecretory compounds for extended relief. Such compounds work by reducing or obstructing the secretion of body fluids, especially gastric acid, through specific cellular pathways or receptors. For example, in June 2024, Akums Drugs and Pharmaceuticals, an Indian pharmaceutical firm, introduced a new Rabeprazole + Levosulpiride SR Capsules for patients with gastrointestinal issues. This unique formulation combines rabeprazole sodium, an effective antisecretory agent that selectively suppresses H?/K? ATPase in gastric parietal cells, with levosulpiride – known for its central antidopaminergic and antiemetic characteristics. The capsule consists of 40 mg of enteric-coated rabeprazole and 75 mg of sustained-release levosulpiride to ensure targeted and extended therapy. It targets both acid suppression and gastrointestinal motility regulation with its dual action mechanism.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/gastric-antisecretory-drug-global-market-report
Which Countries Are Leading the Gastric Antisecretory Drug Market?
North America was the largest region in the gastric antisecretory drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric antisecretory drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24222&type=smp
This Report Delivers Insight On:
1. How big is the gastric antisecretory drug market, and how is it changing globally?
2. Who are the major companies in the gastric antisecretory drug market, and how are they performing?
3. What are the key opportunities and risks in the gastric antisecretory drug market right now?
4. Which products or customer segments are growing the most in the gastric antisecretory drug market?
5. What factors are helping or slowing down the growth of the gastric antisecretory drug market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model